BSE filing, NSE: STANDARD. Summary written from the filing by ALFA Finder's alert engine.
Standard Surfactants Ltd: key numbers
- Share price
- ₹138.90
- Market cap
- ₹114.8 Cr
- Revenue (annual)
- ₹244.2 Cr
- Net profit (annual)
- ₹3.33 Cr
- P/E (TTM)
- 12.5×Sector 34.1×
- Promoter holding
- 62.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Standard Surfactants Ltd
All →Standard Surfactants Other Announcement
The company submitted its quarterly shareholding pattern as per Regulation 31, detailing the distribution of shareholding among various categories of shareholders.
Standard Surfactants Annual General Meeting
Standard Surfactants Ltd held its 37th Annual General Meeting on 30th September 2026. The meeting covered adoption of financial statements and related party transaction approvals.
Standard Surfactants Annual General Meeting
Standard Surfactants Ltd has submitted its 37th Annual Report for FY 2025-26 and notice for the AGM scheduled on September 30, 2026.
Standard Surfactants Promoter Buying (Off-Market): ₹0.34 Cr
Promoter group members executed inter-se off-market transfers involving 58,000 shares totaling ₹0.34 Crore. The transactions reflect internal realignment within the Garg family.
- Value
- ₹0.34 Cr
Standard Surfactants Q1 FY27 Results: Net Profit ₹6.3 Cr, Up 1160.0% YoY
Standard Surfactants Ltd reported revenue from operations of ₹102.4 Cr (+93.2% YoY) and net profit of ₹6.3 Cr (+1160.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹6.3 Cr · +1160.0% YoY
Standard Surfactants Board Meeting Outcome
Standard Surfactants Ltd held a board meeting approving the Q1 FY 2026-27 unaudited financial results. The company also announced the upcoming 37th AGM date and auditor appointment.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.